Eugia Pharma receives USFDA Approval for Amphotericin B Liposome for Injection

Eugia Pharma Specialities Limited, has received a final approval from the US Food & Drug Administration for Amphotericin B Liposome for Injection, 50 mg.

Related Keywords

Taiwan ,Eugia Pharma ,Ambisome Liposome ,Eugia Pharma Specialities ,Biopharm Company ,Astellas Pharma Us Inc ,Us Food Drug Administration ,Aurobindo Pharma ,Eugia Pharma Speciality Group ,Amphotericinb Liposome ,Pharma Limited ,Eugia Pharma Specialities Limited ,Drug Administration ,Single Dose Vial ,Astellas Pharma ,Company Limited ,Cryptococcal Meningitis ,Aurobindo Pharma Limited ,Aurobindopharma ,Ine406a01037 ,Eugiapharmaspecialities ,Finalapproval ,Usfda ,Amphotericinbliposome ,Injection ,